[Federal Register Volume 62, Number 161 (Wednesday, August 20, 1997)]
[Notices]
[Pages 44282-44283]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22088]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Blood Products Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA regulatory issues.
Date and Time: The meeting will be held on September 18, 1997, 8
a.m. to 5:30 p.m., and September 19, 1997, 8 a.m. to 4 p.m.
Location: Quality Suites Hotel, Potomac Rooms I, II, and III, Three
Research Ct. (off Shady Grove Rd.), Rockville, MD.
Contact Person: Linda A. Smallwood, Center for Biologics Evaluation
and Research (HFM-350), Food and Drug Administration, 1401 Rockville
Pike, Rockville, MD 20852, 301-827-3514, or FDA Advisory Committee
Information
[[Page 44283]]
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code
12388. Please call the Information Line for up-to-date information on
this meeting.
Agenda: On the morning of September 18, 1997, the committee will
discuss the topic of inadvertent contamination of plasma. In the
afternoon, the committee will hear a proposal for management of plasma
and plasma donors presented by the International Plasma Products
Industry Association. On September 19, 1997, the committee will discuss
the topic of cryoprecipitate-depleted plasma.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by September 10,
1997. Oral presentations from the public will be scheduled between
approximately 11 a.m. and 11:30 a.m. and 2 p.m. and 3 p.m. on September
18, 1997. Time allotted for each presentation may be limited. Those
desiring to make formal oral presentations should notify the contact
person before September 10, 1997, and submit a brief statement of the
general nature of the evidence or arguments they wish to present, the
names and addresses of proposed participants, and an indication of the
approximate time requested to make their presentation.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: August 14, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-22088 Filed 8-19-97; 8:45 am]
BILLING CODE 4160-01-F
